Diazepam Intensol

Athetosis, Lockjaw, Syndrome + 11 more

Treatment

20 Active Studies for Diazepam Intensol

What is Diazepam Intensol

Diazepam

The Generic name of this drug

Treatment Summary

Diazepam is a medication used to treat severe anxiety, insomnia, seizures, muscle spasms, and alcohol withdrawal. It helps to relax the body and can be administered in different ways. In 2015-2016, an auto-injector was developed and approved by the US FDA that administers diazepam quickly and easily through a subcutaneous injection, allowing for fast and consistent absorption of the drug. This is a useful tool to help patients with epilepsy manage their seizures.

Valium

is the brand name

Diazepam Intensol Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Valium

Diazepam

1963

289

Effectiveness

How Diazepam Intensol Affects Patients

Diazepam is a benzodiazepine that helps reduce anxiety, make you feel sleepy, relax your muscles, prevent seizures, and helps you forget things. Most of these effects are caused by making it easier for the neurotransmitter GABA to do its job in the brain. GABA is a chemical that helps keep the brain calm.

How Diazepam Intensol works in the body

Diazepam is a drug that helps relieve tension, muscle spasms, and seizures. It does this by interacting with certain parts of the brain and spinal cord, which increases the calming effects of GABA. GABA helps with sleep, anxiety, memory, and controlling overactive nerves.

When to interrupt dosage

The quantity of Diazepam Intensol is contingent upon the diagnosed affliction, including Muscle Tissue, Seizures and Anger Management Therapy. The measure of dosage is contingent upon the technique of delivery as indicated in the table underneath.

Condition

Dosage

Administration

Drug Resistant Epilepsy

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Seizures

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Anger Management Therapy

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Muscle Tissue

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Athetosis

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Lockjaw

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Syndrome

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Motor Neuron Disease, Upper

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Sedation therapy

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Sedation

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Generalized Anxiety Disorder

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Anxiety Disorders

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Stiff-Person Syndrome

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Status Epilepticus

5.0 mg/mL, , 25.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 5.0 mg, 10.0 mg, 2.0 mg, 1.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 15.0 mg/mL

, Oral, Solution - Oral, Solution, Gel, Gel - Rectal, Rectal, Tablet, Tablet - Oral, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, solution, Kit, Liquid - Intramuscular; Intravenous, Liquid, Emulsion, Emulsion - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Solution - Intramuscular; Intravenous, Injection - Intramuscular, Intramuscular, Injection, Liquid - Intramuscular, Cream - Topical, Cream, Topical, Injection - Intramuscular; Intravenous, Nasal, Spray - Nasal, Spray

Warnings

Diazepam Intensol has six contraindications and should be abstained from when encountering any of the circumstances detailed in the following table.

Diazepam Intensol Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Obstructive Sleep Apnea (OSA)

Do Not Combine

Glaucoma

Do Not Combine

Myasthenia Gravis

Do Not Combine

Liver Failure

Do Not Combine

Respiratory Insufficiency

Do Not Combine

There are 20 known major drug interactions with Diazepam Intensol.

Common Diazepam Intensol Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Diazepam.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Diazepam.

Azelastine

Major

Diazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Diazepam.

Copanlisib

Major

The metabolism of Copanlisib can be decreased when combined with Diazepam.

Diazepam Intensol Toxicity & Overdose Risk

Symptoms of diazepam overdose may include increased drowsiness, unsteadiness, muscle weakness, sleepiness, low blood pressure, slow heartbeat, shaking eyes, and paradoxical excitement. In extreme cases, this may lead to coma, lack of reflexes, breathing problems, and apnea. People with severe respiratory problems may experience more severe effects. Taking diazepam with other substances that can cause drowsiness, such as alcohol, may be fatal. Pregnant women and those breastfeeding should not take diazepam. The drug can pass into breastmilk. Infants under 6 months old should not receive diazepam

image of a doctor in a lab doing drug, clinical research

Diazepam Intensol Novel Uses: Which Conditions Have a Clinical Trial Featuring Diazepam Intensol?

409 active studies are investigating the potential of Diazepam Intensol to manage Anxiety Disorders, Generalized Anxiety Disorder and Stiff Man Syndrome.

Condition

Clinical Trials

Trial Phases

Anxiety Disorders

56 Actively Recruiting

Phase 2, Not Applicable, Phase 4, Phase 3, Early Phase 1

Generalized Anxiety Disorder

183 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4, Phase 1, Phase 3

Syndrome

4 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Lockjaw

0 Actively Recruiting

Stiff-Person Syndrome

4 Actively Recruiting

Phase 2, Phase 1

Sedation

2 Actively Recruiting

Early Phase 1, Not Applicable

Motor Neuron Disease, Upper

0 Actively Recruiting

Athetosis

1 Actively Recruiting

Phase 3

Drug Resistant Epilepsy

1 Actively Recruiting

Not Applicable

Sedation therapy

0 Actively Recruiting

Status Epilepticus

0 Actively Recruiting

Seizures

0 Actively Recruiting

Muscle Tissue

0 Actively Recruiting

Anger Management Therapy

0 Actively Recruiting

Diazepam Intensol Reviews: What are patients saying about Diazepam Intensol?

5

Patient Review

1/27/2010

Diazepam Intensol for Anxious

I've been taking this medication for over 30 years, and recently the effects have lessened. I still experience anxiety and depression even with the dosage of 10mg 3x daily. Are there other options out there that could provide better results?
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about diazepam intensol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is an Intensol medication?

"Lorazepam Intensol is a medication used to treat anxiety disorders. It may also be used for other purposes not listed in this guide."

Answered by AI

How do you administer diazepam Intensol?

"Use the Intensol as directed by your health care provider.

Draw the amount of Intensol prescribed for a single dose into the dropper. Then, squeeze the dropper contents into a liquid or semi-solid food. Stir the liquid or food gently for a few seconds. The Intensol formulation will blend quickly and completely. Follow the directions given to you by your health care provider when using Intensol."

Answered by AI

What is 5mg of diazepam used for?

"uk Diazepam is commonly used to treat anxiety, muscle spasms and seizures."

Answered by AI

What is lorazepam Intensol used for?

"This medication is used to treat anxiety by enhancing the effects of a natural chemical in the body known as GABA."

Answered by AI

Clinical Trials for Diazepam Intensol

Have you considered Diazepam Intensol clinical trials?

We made a collection of clinical trials featuring Diazepam Intensol, we think they might fit your search criteria.
Go to Trials
Image of Fred Hutch/University of Washington Cancer Consortium in Seattle, United States.

Psilocybin Therapy for Anxiety and Depression in Cancer

18 - 85
All Sexes
Seattle, WA

This phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) or with hematologic cancers for which no treatment is currently available (incurable). For patients with metastatic, incurable cancer, unrelieved anxiety and existential distress can cause profound suffering. Psilocybin therapy can relieve anxiety and existential distress by disrupting patterns of thinking that contribute to anxiety and depression. Psilocybin is a substance being studied in the treatment of anxiety or depression in patients with cancer. In this study, a pharmaceutical grade of psilocybin will be used that has been approved by the FDA for research, provided by Filament Health. Psilocybin acts on the brain by resetting the brain's activity and increasing connections between brain regions, particularly those involved in mood regulation and self-perception. In this study psilocybin is combined with structured discussions and reflections that enable patients to have new insights about their situation. In a prior study, group retreat psilocybin therapy was proven to be safe and this study tests a refined dosing regimen for symptoms of anxiety and depression in patients with metastatic solid tumors or incurable hematologic malignancies.

Phase 2
Waitlist Available

Fred Hutch/University of Washington Cancer Consortium

Anthony Back, MD

Image of Wahwala Iyohlogya/Peaceful Means in Pine Ridge, United States.

Lakota Family Acceptance Program for Depression and Anxiety

Any Age
All Sexes
Pine Ridge, SD

The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also examine pre- to post- changes on outcomes for the sole purposes of making sure scores on measures are changing in the hypothesized direction (e.g., depression scores are going from moderate to minimal as opposed to no change or depression scores increasing). Once enrolled in the study, participants complete a baseline survey. Then participants will engage in LFAP which is an 8-session group intervention; sessions will be scheduled once a week for eight weeks (at 2 hours per session). Participants will complete survey instruments before and immediately after the program sessions, in addition to post-program surveys and an exit interview.

Recruiting
Has No Placebo

Wahwala Iyohlogya/Peaceful Means (+1 Sites)

Katie Edwards, PhD

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Have you considered Diazepam Intensol clinical trials?

We made a collection of clinical trials featuring Diazepam Intensol, we think they might fit your search criteria.
Go to Trials
Image of Fort Bend ISD in Sugar Land, United States.

Wellbeing Interventions for Anxiety

10 - 20
All Sexes
Sugar Land, TX

The goal of this clinical trial is to learn if psychology and music based interventions can impact anxiety and overall wellbeing in adolescents enrolled in choral music classes. The main questions it aims to answer are: Do specific psychology and music based breathing interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based performance anxiety reduction interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based emotion regulation interventions impact anxiety and overall wellbeing in adolescents? Researchers will compare results of pre-test data, post-test data, qualitative interviews, and surveys of adult choral directors to see if there is a measurable impact on adolescent anxiety and overall wellbeing. Participants will: * Use box breathing during choral music warm-ups to connect choral breathing to breathing for anxiety reduction * Use "magnify" technique to compare cognitive distortions regarding an upcoming performance that may cause anxiety to the most likely realistic outcome * Use emotion regulation through song lyrics technique to connect lyrics of choral music repertoire to participants experienced emotions

Waitlist Available
Has No Placebo

Fort Bend ISD

Jane Kuehne, PhD

Image of Birmingham VA in Birmingham, United States.

Transcranial Alternating Current Stimulation for Anxiety

19 - 70
All Sexes
Birmingham, AL

Transcranial alternating current stimulation (tACS) in a wearable brain stimulation device that delivers a low intensity, pulsed, alternating current via scalp electrodes. Prior sham-controlled clinical trials have shown the therapeutic effects and safety of tACS for the treatment of anxiety and depression. In addition, tACS is rapid acting and well tolerated. After the device is issued to the patient during an in-office orientation and training session, the tACS device can be safely used by the patient at the convenience of their own home. Up to 40 Veterans under that age of 70 who have clinically significant anxiety will be enrolled in an 8-week open-label trial of Model FW-200 tACS to evaluate feasibility, acceptability, adherence and impact on anxiety, depression, post-traumatic stress disorder (PTSD), sleep and neurocognitive measures. Participants may have a concurrent diagnosis of major depressive disorder (MDD) and/or PTSD.

Recruiting
Has No Placebo

Birmingham VA

Lori Davis, MD

Fisher Wallace Laboratories

Have you considered Diazepam Intensol clinical trials?

We made a collection of clinical trials featuring Diazepam Intensol, we think they might fit your search criteria.
Go to Trials